[News Brief] Merck Opens BioReliance Testing Facility in Germany
Merck has opened a 2,000-square-metre BioReliance testing facility at its headquarters in Darmstadt, Germany. The site provides commercial drug substance,…
Press Release
[News Brief] True Chiropractic Outlines Role of Chiropractic Care in Preventive Healthcare
True Chiropractic has outlined its chiropractic care approach within preventive healthcare strategies, highlighting the relationship between spinal health, nervous system…
[News Brief] ICMCM 2026 Gathers Global Chinese Medicine Experts in Hong Kong
The 25th International Conference of the Modernization of Chinese Medicine and Health Products (ICMCM) will take place from 13 to…
[News Brief] MAXONA Pharmaceuticals Receives FDA Clearance for Pain Therapy Trial
MAXONA Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its Investigational New Drug (IND) application…
[News Brief] National University Hospital to Expand Wearable Inpatient Monitoring
The National University Hospital (NUH) in Singapore is set to expand the use of wearable technology for inpatient vital signs…
[News Brief] Telix Opens Integrated Radiopharmaceutical Facility in Australia
Telix Pharmaceuticals Limited has opened Telix Manufacturing Solutions North Melbourne (TMSNM), a purpose-built radiopharmaceutical research, manufacturing and treatment facility in…
[News Brief] Cordex Biologics Grants FarmaMondo Distribution Rights for Zemcelpro®
Cordex Biologics has entered into an agreement granting FarmaMondo SA distribution rights for its cell therapy product, Zemcelpro® (dorocubicel), in…
[News Brief] ALR Technologies Signs LOI to Acquire CGM Medical Technology Assets for US$45 Million
ALR Technologies SG has signed a Letter of Intent (LOI) to acquire 100% of CGM Medical Technology Singapore and selected…
[News Brief] StarMed Obtains US FDA Clearance for Thyroid Nodule Ablation System
South Korea-based StarMed Co., Ltd. has received US Food and Drug Administration (FDA) 510(k) clearance for its radiofrequency ablation (RFA)…
[News Brief] Insilico Medicine Initiates Phase III Trial for AI-Discovered IPF Drug Candidate
Insilico Medicine has initiated a Phase III clinical trial evaluating Rentosertib (formerly ISM001-055/INS018_055), an orally administered small-molecule TNIK inhibitor for…